IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 57.11

Change

+0.22 (+0.39)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+1.00 (+0.65%)

USD 41.71B
FHLC Fidelity® MSCI Health Care In..

+0.46 (+0.64%)

USD 2.97B
FXH First Trust Health Care AlphaD..

+0.42 (+0.37%)

USD 1.29B
XHE SPDR® S&P Health Care Equipme..

+0.67 (+0.75%)

USD 0.22B
IDNA iShares Genomics Immunology an..

+0.05 (+0.22%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

+0.06 (+0.16%)

USD 0.11B
XHS SPDR® S&P Health Care Service..

+0.62 (+0.64%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

+0.10 (+0.33%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

-0.03 (-0.05%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.06 (+0.20%)

USD 0.01B

ETFs Containing IHF

LCR Leuthold Core ETF 4.21 % 0.00 %

+0.08 (+0.24%)

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.76% 36% F 52% F
Dividend Return 0.58% 47% F 9% A-
Total Return 9.34% 45% F 45% F
Trailing 12 Months  
Capital Gain 15.33% 7% C- 47% F
Dividend Return 0.82% 47% F 9% A-
Total Return 16.15% 7% C- 42% F
Trailing 5 Years  
Capital Gain 79.68% 98% N/A 79% B-
Dividend Return 4.81% 58% F 13% F
Total Return 84.49% 98% N/A 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 9.21% N/A N/A 66% D+
Dividend Return 9.84% N/A N/A 61% D-
Total Return 0.63% N/A N/A 15% F
Risk Return Profile  
Volatility (Standard Deviation) 16.93% N/A N/A 60% D-
Risk Adjusted Return 58.13% N/A N/A 75% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike